PERSPECTA

News from every angle

← Back to headlines

FDA Issues Early Alert Regarding Medtronic Bravo CF Capsule Delivery Device

The US Food and Drug Administration has issued an early alert concerning safety or performance issues related to Medtronic's Bravo CF capsule delivery system.

27 Aug, 16:04 — 27 Aug, 16:04
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed8h ago

Medtronic Bravo CF capsule delivery device focus of FDA Early Alert

Read full article →

Related Stories

US Nears Deal to Secure Long-Term Stake in Venezuelan Oil Reserves

26m ago

Cathie Wood’s ARK Invest Sells AMD and Tempus AI Stakes

51m ago

Nvidia Temporarily Halts Revenue-Sharing Agreements With AI Cloud Providers

1h ago

TotalEnergies Completes Exit From Russia’s Arctic LNG 2 Project

1h ago